Cheng, Fong-Yu <br/><br/>
Promising therapeutic effect of thapsigargin nanoparticles on chronic kidney disease through the activation of Nrf2 and FoxO1.  [electronic resource] 

 -  Aging  11 2019 
 - 9875-9892 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1945-4589 
<br/><br/><label>Standard No.: </label>10.18632/aging.102437  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenine<br/>Animals<br/>Autophagy--drug effects<br/>Cell Line<br/>Drug Evaluation, Preclinical<br/>Endoplasmic Reticulum Stress--drug effects<br/>Forkhead Box Protein O1--metabolism<br/>Humans<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>NF-E2-Related Factor 2--metabolism<br/>Nanoparticles--chemistry<br/>Renal Insufficiency, Chronic--drug therapy<br/>Thapsigargin--administration & dosage